{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:06:59Z","timestamp":1788854819208,"version":"build-2803163510"},"reference-count":138,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.autrev.2026.104143","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:33:21Z","timestamp":1784676801000},"page":"104143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANCA-associated vasculitis: From immunopathogenesis to diagnosis and toward precision therapy"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4570-062X","authenticated-orcid":false,"given":"Tom\u00e1s G.","family":"Domingos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-1122","authenticated-orcid":false,"given":"Henrique","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-0028","authenticated-orcid":false,"given":"V\u00edtor","family":"Silvestre-Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-4166","authenticated-orcid":false,"given":"Teresa M.","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104143_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0010","article-title":"History of antineutrophil cytoplasmic autoantibodies: milestones in rheumatology","author":"de Groot","year":"2024","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092573","article-title":"Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis","volume":"11","author":"Redondo-Rodriguez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated vasculitis: core curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0025","article-title":"Diagnostic and therapeutic approach in ANCA-associated glomerulonephritis: a review on management strategies","volume":"9","author":"Moln\u00e1r","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2026.104143_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197319","article-title":"Immunopathogenesis of ANCA-associated vasculitis","volume":"21","author":"Kronbichler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104143_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfaa303","article-title":"Increasing incidence and improved survival in ANCA-associated vasculitis - a Danish nationwide study","volume":"37","author":"Nelveg-Kristensen","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0045","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","article-title":"Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"30","author":"Watts","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002949","article-title":"Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study","volume":"9","author":"Rathmann","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104143_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005526","article-title":"Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort study","volume":"11","author":"Kilian","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104143_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101845","article-title":"Classification and epidemiology of vasculitis: emerging concepts","volume":"37","author":"Ecclestone","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0070","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/ckj\/sfad225","article-title":"The impact of reclassification by the 2022 ACR\/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis","volume":"16","author":"Van Leeuwen","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2026.104143_bb0075","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0523-y","article-title":"Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis","volume":"11","author":"Iudici","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2021.02.002","article-title":"Granulomatosis with polyangiitis: study of 795 patients from the French Vasculitis study group registry","volume":"51","author":"Iudici","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102467","article-title":"Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry","volume":"112","author":"Nguyen","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104143_bb0100","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1093\/rheumatology\/keaa805","article-title":"Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"60","author":"Papo","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0105","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","article-title":"Association of granulomatosis with polyangiitis (Wegener\u2019s) with HLA-DPB1*04 and SEMA6A gene variants evidence from genome-wide analysis","volume":"65","author":"Xie","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis Europe PMC funders group","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0115","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/annrheumdis-2015-207601","article-title":"Genetic variants in ANCA-associated vasculitis: a meta-analysis","volume":"75","author":"Rahmattulla","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf265","article-title":"Meta-analysis revealed HLA susceptibility markers in ANCA-associated vasculitis and its clinical subtypes","author":"Singh","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0125","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0130","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener\u2019s granulomatosis","volume":"52","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0135","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","article-title":"Alpha\u2081-antitrypsin deficiency-related alleles Z and S and the risk of Wegener\u2019s granulomatosis","volume":"62","author":"Mahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/antib12010025","article-title":"New insights into pathogenesis and treatment of ANCA-associated vasculitis: autoantibodies and beyond","volume":"12","author":"Paroli","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.autrev.2026.104143_bb0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","article-title":"The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis","volume":"12","author":"G\u00f3mez-Puerta","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177482","article-title":"The influence of the great East Japan earthquake on microscopic polyangiitis: a retrospective observational study","volume":"12","author":"Takeuchi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104143_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0160","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0165","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrrheum.2010.158","article-title":"ANCA-associated vasculitides\u2014advances in pathogenesis and treatment","volume":"6","author":"Chen","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0175","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kem022","article-title":"Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener\u2019s granulomatosis","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0180","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40674-024-00215-5","article-title":"(Levamisole adulterated) Cocaine-induced Vasculitis: what is known\/current evidence","volume":"10","author":"Donkers","year":"2024","journal-title":"Curr Treat Opt Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11926-012-0286-y","article-title":"Pathogenesis of ANCA-associated vasculitis","volume":"14","author":"Cartin-Ceba","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2026.104143_bb0200","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamainternmed.2020.0675","article-title":"Association of cigarette smoking with antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"180","author":"McDermott","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.2009121238","article-title":"ANCA disease: where is this field heading?","volume":"21","author":"Falk","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.autrev.2016.03.007","article-title":"Pathogenesis of ANCA-associated vasculitis: an update","volume":"15","author":"Jarrot","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cei\/uxac002","article-title":"Increased circulating PD-1hiCXCR5\u2212 peripheral T helper cells are associated with disease activity of ANCA-associated vasculitis","volume":"207","author":"Liu","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104143_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1214945","article-title":"Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise","volume":"14","author":"Wojcik","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104143_bb0230","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA vasculitis versus myeloperoxidase- ANCA vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0235","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1681\/ASN.2013060606","article-title":"Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis","volume":"25","author":"Nakazawa","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0240","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2026.104143_bb0245","doi-asserted-by":"crossref","DOI":"10.1159\/000323393","article-title":"Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity","volume":"118","author":"Nagai","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.autrev.2026.104143_bb0250","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0255","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2026.104143_bb0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1261151","article-title":"The involvement of NETs in ANCA-associated vasculitis","volume":"14","author":"Shiratori-Aso","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104143_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1458-y","article-title":"Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway","volume":"19","author":"Miao","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104143_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104143_bb0280","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104143_bb0285","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2026.104143_bb0295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-019-0753-z","article-title":"The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study","volume":"7","author":"Wagner","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.autrev.2026.104143_bb0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2026.104143_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0315","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0320","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cei.13498","article-title":"The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis","volume":"202","author":"Moiseev","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104143_bb0325","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/art.39239","article-title":"Promotion of hypercoagulability in antineutrophil cytoplasmic antibody\u2013associated vasculitis by C5a-induced tissue factor\u2013expressing microparticles and neutrophil extracellular traps","volume":"67","author":"Huang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2026.104143_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2026.104143_bb0340","series-title":"Comprehensive clinical nephrology","first-page":"294","author":"Johnson","year":"2023"},{"key":"10.1016\/j.autrev.2026.104143_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071446","article-title":"ANCA-associated vasculitis: an update","volume":"10","author":"Almaani","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0350","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 clinical practice guideline for the management of Antineutrophil cytoplasmic antibody (ANCA)\u2013associated Vasculitis","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2026.104143_bb0355","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-023-01123-8","article-title":"Cardiovascular disease in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"26","author":"Sayer","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2026.104143_bb0360","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7861\/clinmedicine.17-1-60","article-title":"ANCA-associated vasculitis","volume":"17","author":"Yates","year":"2017","journal-title":"Clin Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0365","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40120-021-00315-7","article-title":"ANCA-associated vasculitic neuropathies: a review","volume":"11","author":"Koike","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2026.104143_bb0375","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/keaa667","article-title":"Prevalence and risk factors of relapse in patients with ANCA-associated vasculitis receiving cyclophosphamide induction: a systematic review and meta-analysis of large observational studies","volume":"60","author":"He","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0380","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0385","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2022.02.022","article-title":"Glomerular hematuria and the utility of urine microscopy: a review","volume":"80","author":"Saha","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164863","article-title":"Vascular and vasogenic manifestations of systemic ANCA-associated vasculitis with renal involvement in non-contrast brain MRI in patients with acute disease onset","volume":"11","author":"Lubas","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0395","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0038-1669914","article-title":"Antineutrophil cytoplasmic antibody-associated lung fibrosis","volume":"39","author":"Borie","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0400","doi-asserted-by":"crossref","first-page":"i42","DOI":"10.1093\/rheumatology\/keae557","article-title":"Interstitial lung disease, antineutrophil cystoplasmic antibodies and microscopic polyangiitis","volume":"64","author":"Specks","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0405","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0123-2021","article-title":"Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0410","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/rheumatology\/keac623","article-title":"Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice","volume":"62","author":"Chevet","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0415","article-title":"Connective tissue disorder-induced diffuse alveolar hemorrhage: a comprehensive review with an emphasis on airway and respiratory management","volume":"15","author":"Mudgal","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.autrev.2026.104143_bb0420","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/03009740410011271","article-title":"Pulmonary function and high-resolution CT findings five years after disease onset in patients with Wegener\u2019s granulomatosis","volume":"34","author":"Koldingsnes","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0425","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00915-6","article-title":"Imaging in vasculitis","volume":"22","author":"Guggenberger","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2026.104143_bb0430","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.anl.2024.04.002","article-title":"Sinonasal manifestations of granulomatosis with polyangiitis: a retrospective analysis","volume":"51","author":"Tateyama","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.autrev.2026.104143_bb0435","article-title":"Lung involvement in pulmonary vasculitis: a radiological review","volume":"14","author":"Gozzi","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2026.104143_bb0440","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/1754-9485.13471","article-title":"Granulomatosis with polyangiitis: common and uncommon presentations","volume":"66","author":"Tee","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.autrev.2026.104143_bb0445","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000615","article-title":"Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: insights from the DCVAS study","volume":"6","author":"Bischof","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2026.104143_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 International consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0455","series-title":"Methods Mol Biol","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-8949-2_12","article-title":"Antigen-specific detection of autoantibodies against myeloperoxidase (MPO) and proteinase 3 (PR3)","volume":"1901","author":"Vanderlocht","year":"2019"},{"key":"10.1016\/j.autrev.2026.104143_bb0460","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0465","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","article-title":"Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"37","author":"Moura","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0470","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/pgmj.2005.042648","article-title":"Diagnostic approach to patients with suspected vasculitis","volume":"82","author":"Suresh","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.autrev.2026.104143_bb0475","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0480","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2026.104143_bb0485","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.34067\/KID.0000000000000289","article-title":"Evolution of therapy for ANCA-associated vasculitis with kidney involvement","volume":"4","author":"Rajasekaran","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.autrev.2026.104143_bb0490","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0495","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019173","article-title":"Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective observational study","volume":"99","author":"Waki","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2026.104143_bb0500","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0505","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104143_bb0510","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0515","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0520","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3899\/jrheum.090153","article-title":"Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review","volume":"37","author":"Bourr\u00e9-Tessier","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0525","article-title":"Management of antineutrophil cytoplasmic antibody\u2013associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines\/recommendations","volume":"38","author":"Moura","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0530","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis [retracted]","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-026-01081-1","article-title":"Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management","author":"Antonelou","year":"2026","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bib711","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Retraction: avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Rubin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bib712","series-title":"CDER proposes to withdraw approval of TAVNEOS","year":"2026"},{"key":"10.1016\/j.autrev.2026.104143_bib713","series-title":"EMA recommends revoking marketing authorisation for Tavneos","year":"2026"},{"key":"10.1016\/j.autrev.2026.104143_bb0545","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0550","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0555","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0560","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104143_bb0565","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard-2022-223559","article-title":"Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0570","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0575","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/art.39822","article-title":"The pharmacogenomic association of Fc\u03b3 receptors and cytochrome P450 enzymes with response to rituximab or cyclophosphamide treatment in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Cartin-Ceba","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52525-w","article-title":"Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis","volume":"15","author":"Engesser","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104143_bb0585","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O\u2019Reilly","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2026.104143_bb0590","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfy300","article-title":"Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"35","author":"Moran","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0605","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ekir.2025.01.022","article-title":"Obinutuzumab in rituximab-intolerant antineutrophil cytoplasmic antibody\u2013associated vasculitis patients","volume":"10","author":"van Leeuwen","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2026.104143_bb0610","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002742","article-title":"Daratumumab for the treatment of refractory ANCA-associated vasculitis","volume":"9","author":"Ostendorf","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104143_bb0615","author":"Phase 1B"},{"key":"10.1016\/j.autrev.2026.104143_bb0635","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1093\/rheumatology\/keaf397","article-title":"Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases","volume":"64","author":"Liu","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104143_bb0645","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0650","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-025-05883-7","article-title":"Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study","volume":"45","author":"Bekta\u015f","year":"2025","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2026.104143_bb0655","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gfac320","article-title":"Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis","volume":"38","author":"S\u00e1nchez \u00c1lamo","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0660","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2026.104143_bb0665","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.autrev.2014.08.002","article-title":"Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors","volume":"13","author":"Samson","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104143_bb0670","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0675","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.2009.122952","article-title":"Measurement of damage in systemic vasculitis: a comparison of the vasculitis damage index with the combined damage assessment index","volume":"70","author":"Suppiah","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104143_bb0685","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/ndt\/gfae018","article-title":"Long-term outcome of kidney function in patients with ANCA-associated vasculitis","volume":"39","author":"S\u00e1nchez \u00c1lamo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104143_bb0690","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002953","article-title":"Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"9","author":"Samson","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104143_bb0695","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ekir.2024.11.005","article-title":"Explainability of a deep learning-based classification model for antineutrophil cytoplasmic autoantibody\u2013associated glomerulonephritis","volume":"10","author":"Wester Trejo","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2026.104143_bb0700","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1016\/S2665-9913(24)00187-5","article-title":"Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort","volume":"6","author":"Gisslander","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2026.104143_bb0705","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003962","article-title":"Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis","volume":"10","author":"Scott","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104143_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107757","article-title":"Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records","volume":"168","author":"van Leeuwen","year":"2024","journal-title":"Comput Biol Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:12:56Z","timestamp":1788851576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1568997226001576"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104143","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANCA-associated vasculitis: From immunopathogenesis to diagnosis and toward precision therapy","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104143"}}